Jefferies Raises athenahealth (ATHN) Price Target to $58 after Q4, Keeps Hold Rating
Tweet
Share
E-mailGet Alerts ATHN Hot Sheet
Price: $9.59 --0%
Rating Summary:
6 Buy, 22 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
6 Buy, 22 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Jefferies raised its price target on athenahealth (NASDAQ: ATHN) from $50 to $58 following Q4 upside driven by cost control. The firm maintained their Hold rating.
The firm comments, "ATHN is entering a big investment year during which it will undertake more "projects" than normal. These initiatives bring higher costs and a NT headwind to earnings growth, but should ultimately benefit LT margin. We are impressed by the company's growth, but not naive to the challenges of sustaining that. Valuation remains our reservation."
Q1 EPS estimates was cut to from $0.19 to $0.18, but FY12 was maintained at $0.92.
For an analyst ratings summary and ratings history on athenahealth click here. For more ratings news on athenahealth click here.
Shares of athenahealth closed at $64.01 yesterday.
The firm comments, "ATHN is entering a big investment year during which it will undertake more "projects" than normal. These initiatives bring higher costs and a NT headwind to earnings growth, but should ultimately benefit LT margin. We are impressed by the company's growth, but not naive to the challenges of sustaining that. Valuation remains our reservation."
Q1 EPS estimates was cut to from $0.19 to $0.18, but FY12 was maintained at $0.92.
For an analyst ratings summary and ratings history on athenahealth click here. For more ratings news on athenahealth click here.
Shares of athenahealth closed at $64.01 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- New Street Research Upgrades Micron Technology (MU) to Buy
- Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & Co, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
